首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Binding potencies of 3 new beta 2 specific blockers to beta receptors in the ciliary processes and the possible relevance of these drugs to intraocular pressure control.
【2h】

Binding potencies of 3 new beta 2 specific blockers to beta receptors in the ciliary processes and the possible relevance of these drugs to intraocular pressure control.

机译:睫状突中3种新的β2特异性阻滞剂与β受体的结合力以及这些药物与眼内压控制的可能相关性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The binding potencies of 3 new beta 2 blocking drugs to beta receptors in the ciliary processes were studied by means of radioligand techniques. The drugs studied were IPS339, ICI118,551, and Sandoz L1 32-468. The order of potency of these drugs was IPS339 greater than Sandoz L1 32-468 greater than ICI118,551. The beta 2 dissociation constants (KDs) for these drugs were 0.90 nM, 6.60 nM, and 55 nM respectively. These results are compared with those for other adrenergic agents, including timolol. The potential role of topical beta 2 blockers in glaucoma is discussed.
机译:通过放射配体技术研究了3种新的β2阻断药物与睫状突中β受体的结合力。研究的药物为IPS339,ICI118,551和Sandoz L1 32-468。这些药物的效力等级比Sandoz L1 32-468高IPS339,比ICI118,551高。这些药物的β2解离常数(KDs)分别为0.90 nM,6.60 nM和55 nM。将这些结果与其他肾上腺素能药物(包括噻吗洛尔)的结果进行比较。讨论了局部β2受体阻滞剂在青光眼中的潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号